Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Goodwill & Intangibles: 2017-2023

Historic Goodwill & Intangibles for Aclaris Therapeutics (ACRS) over the last 6 years, with Dec 2023 value amounting to $751,000.

  • Aclaris Therapeutics' Goodwill & Intangibles fell 89.82% to $751,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $751,000, marking a year-over-year decrease of 89.82%. This contributed to the annual value of $751,000 for FY2023, which is 89.82% down from last year.
  • Latest data reveals that Aclaris Therapeutics reported Goodwill & Intangibles of $751,000 as of Q4 2023, which was down 89.82% from $7.4 million recorded in Q3 2023.
  • In the past 5 years, Aclaris Therapeutics' Goodwill & Intangibles registered a high of $92.3 million during Q1 2019, and its lowest value of $751,000 during Q4 2023.
  • Over the past 3 years, Aclaris Therapeutics' median Goodwill & Intangibles value was $7.4 million (recorded in 2023), while the average stood at $6.8 million.
  • Per our database at Business Quant, Aclaris Therapeutics' Goodwill & Intangibles skyrocketed by 257.28% in 2019 and then crashed by 92.00% in 2020.
  • Quarterly analysis of 5 years shows Aclaris Therapeutics' Goodwill & Intangibles stood at $25.9 million in 2019, then plummeted by 71.49% to $7.4 million in 2020, then remained steady at $7.4 million in 2021, then remained steady at $7.4 million in 2022, then slumped by 89.82% to $751,000 in 2023.
  • Its last three reported values are $751,000 in Q4 2023, $7.4 million for Q3 2023, and $7.4 million during Q2 2023.